Delivery Order SPE2DB22D2206-SPE2DB25FJL73
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 5, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The contract involves no set-aside designation, indicating it was competitively awarded. Performance will...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $11,187.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 14, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (quantity 60) on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Calquence is a pharmaceutical product used in the treatment of hematologic...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg on July 23, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price, non-competitive set-aside delivery order was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. As a child contract, this award is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJL73Delivery Order
The Defense Logistics Agency awarded a $22,375.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with performance to be completed by September 9, 2025. This contract award employs firm fixed price terms and carries no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. Calquence, used primarily for treatment of certain hematologic malignancies, falls within the company's comprehensive portfolio of specialty medications provided to the Defense Health Agency and other federal healthcare systems. AmerisourceBergen's consistent receipt of competitively awarded contracts across multiple therapeutic domains demonstrates its established capability as a critical vendor for federal pharmaceutical procurement and medical supply chain support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 8/18/25 |